Specialty code 174400000X · Memphis, TN
NPI
1023019825
Since 2005
Specialty
Specialty code 174400000X
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2225 Union Ave, Ste. 100
Memphis, TN, 38104
Phone (901) 726-1161
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
126 services
Medicare patients, 2024
75
Average age 71
Drug cost, 2024
$996K
596 prescriptions
Company payments, 2024
$818
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc H Stegman was code 99213 (office e&m - established), 36 times for 34 patients. In total Marc H Stegman billed 126 services in 7 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 36 | 34 | $54.37 | $1,957 |
| 99214 Office E&M - Established | Office | 34 | 28 | $86.51 | $2,941 |
By year: 2022 $56K for 399 services; 2023 $38K for 300 services; 2024 $15K for 126 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marc H Stegman prescribed most often to Medicare patients was Velphoro (Sucroferric Oxyhydroxide), with 60 prescriptions and refills. In total Marc H Stegman wrote 596 Medicare prescriptions that cost $996K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Velphoro Sucroferric Oxyhydroxide | 60 | 66 | 11 | $160K |
| Amlodipine Besylate Generic | 59 | 155 | 21 | $170 |
| Hydralazine Hcl Generic | 29 | 87 | 11 | $575 |
| Carvedilol Generic | 28 | 60 | Under 11 | $145 |
| Sevelamer Carbonate Generic | 25 | 43 | Under 11 | $6,436 |
| Prednisone Generic | 25 | 73 | Under 11 | $192 |
| Farxiga Dapagliflozin Propanediol | 24 | 39 | Under 11 | $22K |
| Fabrazyme Agalsidase Beta | 24 | 24 | Under 11 | $730K |
| Rosuvastatin Calcium Generic | 18 | 46 | Under 11 | $91.12 |
| Xphozah Tenapanor Hcl | 18 | 20 | Under 11 | $56K |
| Allopurinol Generic | 16 | 48 | Under 11 | $173 |
| Furosemide Generic | 15 | 43 | Under 11 | $31.06 |
| Atorvastatin Calcium Generic | 14 | 42 | Under 11 | $216 |
| Losartan Potassium Generic | 13 | 37 | Under 11 | $150 |
| Hydrochlorothiazide Generic | 12 | 36 | Under 11 | $30.94 |
Brand drugs: 142 claims; generic drugs: 454 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Marc H Stegman $818 ($818 in general payments such as food, travel and fees) from 8 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $212.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $212 |
| Ardelyx, Inc. ARDX | 5 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $145 |
| Fresenius USA Marketing, Inc. | 4 | $84.94 |
| Travere Therapeutics, Inc. TVTX | 3 | $63.82 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $51.67 |
| Mallinckrodt Hospital Products Inc. | 1 | $33.12 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $24.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.